Background
Broadly neutralizing antibodies (bnAbs) can prevent HIV acquisition but are challenging to elicit by vaccination. Infants living with HIV more readily develop bnAbs, raising the hypothesis that vaccine-induced bnAbs may be more easily generated in infants. This study investigates the induction of antibody (Ab) responses in infants vaccinated with CH505TF gp120 adjuvanted with glucopyranosyl lipid A-stable emulsion (GLA-SE), and evaluates how these responses compare to adults who received the same vaccine regimen.
Methods
Infants born to mothers living with HIV (HVTN 135 in South Africa) and healthy adults (HVTN 115 in the US) received five doses of 20µg of a clade C gp120, CH505TF, with GLA-SE on a harmonized vaccination schedule. HIV-1 IgG binding Ab (bAb), FcR engagement, and antigen-specific B cell frequencies were assessed at baseline and 2 weeks post-5th vaccination (Week 56) by bAb multiplex assay and flow cytometry. Ab-mediated cellular cytotoxicity and Ab-dependent cellular phagocytosis were evaluated at the same timepoints. Neutralizing Ab (nAb) responses were measured by the TZM-bl assay. Pediatric Vaccine Multiplex Assay assessed Ab responses to routine childhood vaccines (HiB, HepB, Diphtheria, Tetanus and Pertussis).
Results
CH505+ B cells, CH505 gp120-specific bAbs, and Tier 1A nAbs were detected in all CH505-vaccinated infants. CD4 binding-site-specific bAbs were detected in >80% of infants, while phagocytic activity showed a ~2-fold improvement over baseline. When compared to adults, the IgG binding response, FcR engagement, and Tier 1A nAb response in infants was higher (geometric mean (GM) IgG CH505 gp120 AUC = 17731 vs. 4482; FcγRIIIa CH505 gp120 net MFI GM = 2415 vs. 256 adults; nAb GM CH505.w4.3 ID50 = 3502 vs. 181). Week 56 binding responses to the vaccine-matched antigen had low correlation with baseline binding responses (corr=0.24), suggesting maternal Ab interference was not detected. Infants in the CH505 gp120 and placebo groups had similar responses to routine childhood vaccines.
Conclusions
Infants elicited Ab responses with a magnitude and quality that were comparable to, or higher than adults, especially nAb and FcR binding. Further, maternal Abs did not interfere with vaccine humoral immunogenicity in infants and the vaccine did not alter infant humoral responses to childhood vaccinations. These results indicate potential improvements in the quality of Abs elicited early in life and support continued investigation of HIV vaccines in infants.